Beijing Strong Biotechnologies, Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 814.59 million compared to CNY 711.06 million a year ago. Revenue was CNY 816.33 million compared to CNY 712.01 million a year ago.

Net income was CNY 241.57 million compared to CNY 162.85 million a year ago. Basic earnings per share from continuing operations was CNY 0.41 compared to CNY 0.28 a year ago. Diluted earnings per share from continuing operations was CNY 0.41 compared to CNY 0.28 a year ago.